References
-
Wang, Z. et al. Effect of monosaccharide composition and proportion on the bioactivity of polysaccharides: a review. Int. J. Biol. Macromol. 254, 127955 (2024).
-
Cheong, K.-L., Chen, W., Wang, M., Zhong, S. & Veeraperumal, S. Therapeutic prospects of Undaria pinnatifida polysaccharides: extraction, purification, and functional activity. Mar. Drugs 23, 163 (2025).
-
Cheong, K.-L. et al. Trends in polysaccharide-based hydrogels for skin anti-aging and skin antioxidant. Int. J. Biol. Macromol. 319, 145366 (2025).
-
Ferreira, S. S., Passos, C. P., Madureira, P., Vilanova, M. & Coimbra, M. A. Structure–function relationships of immunostimulatory polysaccharides: a review. Carbohydr. Polym. 132, 378–396 (2015).
-
Teferra, T. F. Possible actions of inulin as prebiotic polysaccharide: a review. Food Front. 2, 407–416 (2021).
-
Cheong, K.-L., Sabir, A., Wang, M., Zhong, S. & Tan, K. Advancements in the extraction, characterization, and bioactive potential of laminaran: a review. Foods 14, 1683 (2025).
-
Ho Do, M., Seul, S. Y. & Park, H.-Y. Polysaccharides: bowel health and gut microbiota. Crit. Rev. Food Sci. Nutr. 61, 1212–1224 (2021).
-
Johansson, M. E. V. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064–15069 (2008).
-
McGuckin, M. A. & Hasnain, S. Z. Goblet cells as mucosal sentinels for immunity. Mucosal Immunol. 10, 1118–1121 (2017).
-
Stanforth, K. J. et al. The MUC2 gene product: polymerisation and post-secretory organisation—current models. Polymers 16, 1663 (2024).
-
Liu, Y. et al. Orchestration of MUC2—the key regulatory target of gut barrier and homeostasis: a review. Int. J. Biol. Macromol. 236, 123862 (2023).
-
Meldrum, O. W., Yakubov, G. E. Journey of dietary fiber along the gastrointestinal tract: role of physical interactions, mucus, and biochemical transformations. Crit. Rev. Food Sci. Nutr. 65, 1–29 (2024).
-
Albano, K. M., Fazani, C.ÂL. & Nicoletti, V. R. Electrostatic interaction between proteins and polysaccharides: physicochemical aspects and applications in emulsion stabilization. Food Rev. Int. 35, 54–89 (2019).
-
Ferreira, L. M. B. et al. Understanding mucus modulation behavior of chitosan oligomers and dextran sulfate combining light scattering and calorimetric observations. Carbohydr. Polym. 306, 120613 (2023).
-
Surendranath, M., M. R, R. & Parameswaran, R. Recent advances in functionally modified polymers for mucoadhesive drug delivery. J. Mater. Chem. B 10, 5913–5924 (2022).
-
Sauvaitre, T. et al. Tripartite relationship between gut microbiota, intestinal mucus and dietary fibers: towards preventive strategies against enteric infections. FEMS Microbiol. Rev. 45, fuaa052 (2021).
-
Cai, B. et al. Administration of Gracilariopsis lemaneiformis polysaccharide attenuates cisplatin-induced inflammation and intestinal mucosal damage in colon-26 carcinoma tumor-bearing mice. J. Sci. Food Agric. 104, 3757–3766 (2024).
-
Rajagopal, H. M., Manjegowda, S. B., Serkad, C. & Dharmesh, S. M. A modified pectic polysaccharide from turmeric (Curcuma longa) with antiulcer effects via anti-secretary, mucoprotective and IL-10 mediated anti-inflammatory mechanisms. Int. J. Biol. Macromol. 118, 864–880 (2018).
-
Cheong, K.-L., Liu, K., Chen, W., Zhong, S. & Tan, K. Recent progress in Porphyra haitanensis polysaccharides: extraction, purification, structural insights, and their impact on gastrointestinal health and oxidative stress management. Food Chem. X 22, 101414 (2024).
-
Moulzir, M., Hazart, D., Oheim, M., Ricard, C. Label-free, high-resolution fluorescence imaging of the intestinal wall by image scanning and confocal microscopy. Gastro. Hep. Adv. https://doi.org/10.1016/j.gastha.2025.100735 (2025).
-
Özkan, A., LoGrande, N. T., Feitor, J. F., Goyal, G. & Ingber, D. E. Intestinal organ chips for disease modelling and personalized medicine. Nat. Rev. Gastro. Hepat. 21, 751–773 (2024).
-
Gustafsson, J. K. et al. An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G430–G438 (2011).
-
Johansson, M. E. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63, 281–291 (2014).
-
Schroeder, B. O. Fight them or feed them: how the intestinal mucus layer manages the gut microbiota. Gastroenterol. Rep. 7, 3–12 (2019).
-
Cai, R. et al. Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon. Gut Microbes 11, 680–690 (2020).
-
Yu, B. et al. Partially acid-hydrolyzed porphyran improved dextran sulfate sodium-induced acute colitis by modulation of gut microbiota and enhancing the mucosal barrier. J. Agric. Food Chem. 71, 7299–7311 (2023).
-
Martens, E. C., Neumann, M. & Desai, M. S. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457–470 (2018).
-
Li, H. et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun. 6, 8292 (2015).
-
Aggarwal, V., Sunder, S. & Verma, S. R. Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome. Folia Microbiol. 67, 811–824 (2022).
-
Ndeh, D. A. et al. A Bacteroides thetaiotaomicron genetic locus encodes activities consistent with mucin O-glycoprotein processing and N-acetylgalactosamine metabolism. Nat. Commun. 16, 3485 (2025).
-
Herath, M., Hosie, S., Bornstein, J. C., Franks, A. E. & Hill-Yardin, E. L. The role of the gastrointestinal mucus system in intestinal homeostasis: implications for neurological disorders. Front. Cell Infect. Mi. ume 10, 2020 (2020).
-
Birchenough, G. M. H., Johansson, M. E., Gustafsson, J. K., Bergström, J. H. & Hansson, G. C. New developments in goblet cell mucus secretion and function. Mucosal Immunol. 8, 712–719 (2015).
-
Kudelka, M. R., Stowell, S. R., Cummings, R. D. & Neish, A. S. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat. Rev. Gastro. Hepat. 17, 597–617 (2020).
-
Recktenwald, C. V. et al. The structure of the second CysD domain of MUC2 and role in mucin organization by transglutaminase-based cross-linking. Cell Rep. https://doi.org/10.1016/j.celrep.2024.114207 (2024).
-
Song, C. et al. Intestinal mucus components and secretion mechanisms: what we do and do not know. Exp. Mol. Med. 55, 681–691 (2023).
-
Cornick, S., Kumar, M., Moreau, F., Gaisano, H. & Chadee, K. VAMP8-mediated MUC2 mucin exocytosis from colonic goblet cells maintains innate intestinal homeostasis. Nat. Commun. 10, 4306 (2019).
-
Cornick, S., Moreau, F., Gaisano, H. Y., Chadee, K. Entamoeba histolytica-induced mucin exocytosis is mediated by VAMP8 and is critical in mucosal innate host defense. mBio. https://doi.org/10.1128/mbio.01323-17 (2017).
-
Kurzyna-Szklarek, M., Cybulska, J. & Zdunek, A. Analysis of the chemical composition of natural carbohydrates—an overview of methods. Food Chem. 394, 133466 (2022).
-
Ji, X., Yin, M., Nie, H. & Liu, Y. A Review of isolation, chemical properties, and bioactivities of polysaccharides from Bletilla striata. Biomed. Res. Int. 2020, 5391379 (2020).
-
Wang, M. & Cheong, K.-L. Preparation, structural characterisation, and bioactivities of fructans: a review. Molecules 28, 1613 (2023).
-
Ji, X. et al. Effect of inulin on pasting, thermal, rheological properties and in vitro digestibility of pea starch gel. Int. J. Biol. Macromol. 193, 1669–1675 (2021).
-
Yiasmin, M.N. et al. The state-of-the-art on exploring polysaccharide-protein interactions and its mechanisms, stability, and their role in food systems. Food Rev. Int. 41, 1–36 (2025).
-
Fuchs, A., Romeis, D., Hupfeld, E. & Sieber, V. Biocatalytic conversion of carrageenans for the production of 3,6-anhydro-D-galactose. J. Agric. Food Chem. 72, 5816–5827 (2024).
-
Hong, T., Zhao, J., Yin, J., Nie, S., Xie, M. Structural characterization of a low molecular weight HG-type pectin from gougunao green tea. Front. Nutr. 9, 2022 (2022).
-
Liu, K. et al. Pitaya stem polysaccharide promotes wound healing by modulating macrophage polarization via single-cell RNA sequencing evidence. Int. J. Biol. Macromol. 308, 142653 (2025).
-
An, J. et al. Influence of glycosylation on interfacial properties of recombinant mucins: adsorption, surface forces, and friction. Langmuir 33, 4386–4395 (2017).
-
Johansson, M. E. V. et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 5, e12238 (2010).
-
de Almeida, W. S. & da Silva, D. A. Does polysaccharide quaternization improve biological activity?. Int. J. Biol. Macromol. 182, 1419–1436 (2021).
-
Liu, H. et al. Positively charged chitosan and N-trimethyl chitosan inhibit Aβ40 fibrillogenesis. Biomacromolecules 16, 2363–2373 (2015).
-
Corfield, A. P. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim. Biophys. Acta Gen. Subj. 1850, 236–252 (2015).
-
Johansson, M. E. V. et al. Composition and functional role of the mucus layers in the intestine. Cell. Mol. Life Sci. 68, 3635–3641 (2011).
-
Shon, D. J., Kuo, A., Ferracane, M. J. & Malaker, S. A. Classification, structural biology, and applications of mucin domain-targeting proteases. Biochem. J. 478, 1585–1603 (2021).
-
Liu, Y. et al. The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression. Int. J. Biol. Macromol. 164, 884–891 (2020).
-
Sun, L., Zhang, Y., Li, W., Zhang, J. & Zhang, Y. Mucin glycans: a target for cancer therapy. Molecules 28, 7033 (2023).
-
Arike, L. & Hansson, G. C. The densely O-glycosylated MUC2 mucin protects the intestine and provides food for the commensal bacteria. J. Mol. Biol. 428, 3221–3229 (2016).
-
Sanz-Martinez, I., Pereira, S., Merino, P., Corzana, F. & Hurtado-Guerrero, R. Molecular recognition of GalNAc in mucin-type O-glycosylation. Acc. Chem. Res. 56, 548–560 (2023).
-
Liu, J., Jin, C., Cherian, R. M., Karlsson, N. G. & Holgersson, J. O-glycan repertoires on a mucin-type reporter protein expressed in CHO cell pools transiently transfected with O-glycan core enzyme cDNAs. J. Biotechnol. 199, 77–89 (2015).
-
Ye, J. et al. Core 2 mucin-type O-glycan inhibits EPEC or EHEC O157:H7 invasion into HT-29 epithelial cells. Gut Pathog. 7, 31 (2015).
-
Holmén Larsson, J. M., Thomsson, K. A., Rodríguez-Piñeiro, A. M., Karlsson, H. & Hansson, G. C. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G357–G363 (2013).
-
Zhang, Y. et al. Mucin-type O-glycans: barrier, microbiota, and immune anchors in inflammatory bowel disease. J. Inflamm. Res. 14, 5939–5953 (2021).
-
Dupont, A., Lena, H., Klaus, B. & Hornef, M. W. Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa. Gut Microbes 5, 761–765 (2014).
-
Cardoso, M. H., Meneguetti, B. T., Oliveira-Júnior, N. G., Macedo, M. L. R. & Franco, O. L. Antimicrobial peptide production in response to gut microbiota imbalance. Peptides 157, 170865 (2022).
-
Bamias, G., Kitsou, K. & Rivera-Nieves, J. The underappreciated role of secretory IgA in IBD. Inflamm. Bowel Dis. 29, 1327–1341 (2023).
-
Rondelli, V. et al. Mucin thin layers: a model for mucus-covered tissues. Int. J. Mol. Sci. 20, 3712 (2019).
-
Leon-Coria, A., Manish, K. & Chadee, K. The delicate balance between Entamoeba histolytica, mucus and microbiota. Gut Microbes 11, 118–125 (2020).
-
Einhorn, V., Haase, H. & Maares, M. Interaction and competition for intestinal absorption by zinc, iron, copper, and manganese at the intestinal mucus layer. J. Trace Elem. Med. Biol. 84, 127459 (2024).
-
Bayer, I. S. Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies. Adv. Mater. Interfaces 9, 2200211 (2022).
-
Kim, J. et al. N-glycan modifications with negative charge in a natural polymer mucin from bovine submaxillary glands, and their structural role. Polymers 13, 103 (2021).
-
Ding, L., Huang, Y., Cai, X. & Wang, S. Impact of pH, ionic strength and chitosan charge density on chitosan/casein complexation and phase behavior. Carbohydr. Polym. 208, 133–141 (2019).
-
Wang, J. & Zhuang, S. Chitosan-based materials: preparation, modification and application. J. Clean. Prod. 355, 131825 (2022).
-
Liu, X., Dong, Y., Wang, C. & Guo, Z. Application of chitosan as nano carrier in the treatment of inflammatory bowel disease. Int. J. Biol. Macromol. 278, 134899 (2024).
-
Ahmad, M., Ritzoulis, C. & Chen, J. Shear and extensional rheological characterisation of mucin solutions. Colloids Surf. B. Biointerfaces 171, 614–621 (2018).
-
Wang, L., Wu, Y., Li, J., Qiao, H. & Di, L. Rheological and mucoadhesive properties of polysaccharide from Bletilla striata with potential use in pharmaceutics as bio-adhesive excipient. Int. J. Biol. Macromol. 120, 529–536 (2018).
-
Menchicchi, B. et al. Structure of chitosan determines its interactions with mucin. Biomacromolecules 15, 3550–3558 (2014).
-
Yermak, I. M., Davydova, V. N. & Volod’ko, A. V. Mucoadhesive marine polysaccharides. Mar. Drugs 20, 522 (2022).
-
Wu, X. et al. Na+/K+ enhanced the stability of the air/water interface of soy hull polysaccharide and intestinal mucus. Int. J. Biol. Macromol. 245, 125206 (2023).
-
M. Ways, T. M., Lau, W. M. & Khutoryanskiy, V. V. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers 10, 267 (2018).
-
Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103–126 (2020).
-
Hajjar, S. & Zhou, X. pH sensing at the intersection of tissue homeostasis and inflammation. Trends Immunol. 44, 807–825 (2023).
-
Abu Elella, M. H. & Kolawole, O. M. Recent advances in modified chitosan-based drug delivery systems for transmucosal applications: a comprehensive review. Int. J. Biol. Macromol. 277, 134531 (2024).
-
Bal, K. et al. Recent progress in chitosan-based nanoparticles for drug delivery: a review on modifications and therapeutic potential. J. Drug Target. 33, 1–28 (2025).
-
Yang, F. et al. Oral administration of nanoemulsion of supercritical fluid extract of Angelica with quaternized chitosan alleviates ulcerative colitis in mice. Int. J. Biol. Macromol. 314, 144339 (2025).
-
de Oliveira Cardoso, V. M., Gremião, M. P. D. & Cury, B. S. F. Mucin-polysaccharide interactions: a rheological approach to evaluate the effect of pH on the mucoadhesive properties. Int. J. Biol. Macromol. 149, 234–245 (2020).
-
Chen, A. et al. Chain conformation, mucoadhesive properties of fucoidan in the gastrointestinal tract and its effects on the gut microbiota. Carbohydr. Polym. 304, 120460 (2023).
-
An, S. et al. Construction of Hohenbuehelia serotina polysaccharides-mucin nanoparticles and their sustain-release characteristics under simulated gastrointestinal digestion in vitro. Int. J. Biol. Macromol. 191, 1–8 (2021).
-
Yermak, I. M. et al. Mucoadhesive properties of sulphated polysaccharides carrageenans from red seaweed families Gigartinaceae and Tichocarpaceae. Int. J. Biol. Macromol. 142, 634–642 (2020).
-
Schattling, P., Taipaleenmäki, E., Zhang, Y. & Städler, B. A polymer chemistry point of view on mucoadhesion and mucopenetration. Macromol. Biosci. 17, 1700060 (2017).
-
Wang, X. et al. Acetylated polysaccharides: synthesis, physicochemical properties, bioactivities, and food applications. Crit. Rev. Food Sci. Nutr. 64, 4849–4864 (2024).
-
Kashapov, R. et al. Self-assembly of amphiphilic compounds as a versatile tool for construction of nanoscale drug carriers. Int. J. Mol. Sci. 21, 6961 (2020).
-
Käsdorf, B. T. et al. Mucin-inspired lubrication on hydrophobic surfaces. Biomacromolecules 18, 2454–2462 (2017).
-
Prasher, P. et al. Current-status and applications of polysaccharides in drug delivery systems. Colloid Interface Sci. Commun. 42, 100418 (2021).
-
Witten, J., Samad, T. & Ribbeck, K. Selective permeability of mucus barriers. Curr. Opin. Biotechnol. 52, 124–133 (2018).
-
Ho, D.-K. et al. Farnesylated glycol chitosan as a platform for drug delivery: synthesis, characterization, and investigation of mucus–particle interactions. Biomacromolecules 19, 3489–3501 (2018).
-
Ruiz-Pulido, G., Quintanar-Guerrero, D., Serrano-Mora, L. E. & Medina, D. I. Triborheological analysis of reconstituted gastrointestinal mucus/chitosan:TPP nanoparticles system to study mucoadhesion phenomenon under different pH conditions. Polymers 14, 4978 (2022).
-
McClements, D. J. Encapsulation, protection, and release of hydrophilic active components: Potential and limitations of colloidal delivery systems. Adv. Colloid Interface Sci. 219, 27–53 (2015).
-
Wijekoon, M. M. J. O., Mahmood, K., Ariffin, F., Mohammadi Nafchi, A. & Zulkurnain, M. Recent advances in encapsulation of fat-soluble vitamins using polysaccharides, proteins, and lipids: a review on delivery systems, formulation, and industrial applications. Int. J. Biol. Macromol. 241, 124539 (2023).
-
Vaziri, A. S., Alemzadeh, I., Vossoughi, M. & Khorasani, A. C. Co-microencapsulation of Lactobacillus plantarum and DHA fatty acid in alginate-pectin-gelatin biocomposites. Carbohydr. Polym. 199, 266–275 (2018).
-
Geng, W.-C., Jiang, Z.-T., Chen, S.-L. & Guo, D.-S. Supramolecular interaction in the action of drug delivery systems. Chem. Sci. 15, 7811–7823 (2024).
-
Watchorn, J., Stuart, S., Burns, D. C. & Gu, F. X. Mechanistic influence of polymer species, molecular weight, and functionalization on mucin–polymer binding interactions. ACS Appl. Polym. Mater. 4, 7537–7546 (2022).
-
Pecora, T. M. G. et al. Rheological behavior of a new mucoadhesive oral formulation based on sodium chondroitin sulfate, xyloglucan and glycerol. J. Funct. Biomater. 12, 28 (2021).
-
Periasamy, S. et al. Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis. J. Funct. Food 47, 1–10 (2018).
-
Joshi, A., Soni, A. & Acharya, S. In vitro models and ex vivo systems used in inflammatory bowel disease. Vitr. Models 1, 213–227 (2022).
-
Jung, T.-H., Han, K.-S., Park, J.-H. & Hwang, H.-J. Butyrate modulates mucin secretion and bacterial adherence in LoVo cells via MAPK signaling. PLoS One 17, e0269872 (2022).
-
Cai, Y. et al. SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models. Int. J. Pharm. 614, 121461 (2022).
-
Bu, X.-D., Li, N., Tian, X.-Q. & Huang, P.-L. Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer. Tissue Cell 43, 201–206 (2011).
-
Wu, C. et al. Modulation of intestinal epithelial permeability and mucin mRNA (MUC2, MUC5AC, and MUC5B) expression and protein secretion in Caco-2/HT29-MTX co-cultures exposed to aflatoxin M1, ochratoxin A, and zearalenone individually or collectively. Toxicol. Lett. 309, 1–9 (2019).
-
McCoy, R. et al. In vitro models for investigating intestinal host–pathogen interactions. Adv. Sci. 11, 2306727 (2024).
-
Cheong, K.-L. et al. Structure–function relationship of the brown seaweed Undaria pinnatifida laminaran: protein kinase C-mediated mucus secretion and gut barrier restoration. Carbohydr. Polym. 358, 123525 (2025).
-
Kootala, S. et al. Reinforcing mucus barrier properties with low molar mass chitosans. Biomacromolecules 19, 872–882 (2018).
-
Floor, E. et al. Development of a Caco-2-based intestinal mucosal model to study intestinal barrier properties and bacteria–mucus interactions. Gut Microbes 17, 2434685 (2025).
-
Zhao, T. et al. Influence of in vitro pectin fermentation on the human fecal microbiome and O-glycosylation of HT29-MTX cells. Int. J. Biol. Macromol. 284, 137710 (2025).
-
Giromini, C. et al. Role of short chain fatty acids to counteract inflammatory stress and mucus production in human intestinal HT29-MTX-E12 cells. Foods 11, 2022 (1983).
-
Kajiwara-Kubota, M. et al. Partially hydrolyzed guar gum increased colonic mucus layer in mice via succinate-mediated MUC2 production. npj Sci. Food 7, 10 (2023).
-
Hu, W. et al. Endotoxins induced ECM-receptor interaction pathway signal effect on the function of MUC2 in Caco2/HT29 co-culture cells. Front. Immunol. 13, 916933 (2022).
-
Barnett, A. M., Roy, N. C., Cookson, A. L. & McNabb, W. C. Metabolism of caprine milk carbohydrates by probiotic bacteria and Caco-2:HT29–MTX epithelial co-cultures and their impact on intestinal barrier integrity. Nutrients 10, 949 (2018).
-
Meldrum, O. W. & Yakubov, G. E. Journey of dietary fiber along the gastrointestinal tract: role of physical interactions, mucus, and biochemical transformations. Crit. Rev. Food Sci. Nutr. 65, 4264–4292 (2025).
-
Sharma, T. T., Rabizadeh, R. R., Prabhakar, V. S., Bury, M. I. & Sharma, A. K. Evolving experimental platforms to evaluate ulcerative colitis. Adv. Biol. 6, 2200018 (2022).
-
Ruff, W. E., Greiling, T. M. & Kriegel, M. A. Host–microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 18, 521–538 (2020).
-
Johansson, M. E. V. & Hansson, G. C. Immunological aspects of intestinal mucus and mucins. Nat. Rev. Immunol. 16, 639–649 (2016).
-
Xia, B. et al. Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model. Microbiome 10, 139 (2022).
-
Zang, P. et al. Alteration of gastrointestinal function and the ameliorative effects of Hericium erinaceus polysaccharides in tail suspension rats. Nutrients 17, 724 (2025).
-
Wang, Y. et al. Exploring effects of chitosan oligosaccharides on the DSS-induced intestinal barrier impairment in vitro and in vivo. Molecules 26, 2199 (2021).
-
Jiang, S., Xu, H., Zhao, C., Zhong, F. & Li, D. Oyster polysaccharides relieve DSS-induced colitis via anti-inflammatory and maintaining the physiological hypoxia. Int. J. Biol. Macromol. 238, 124150 (2023).
-
Li, M. et al. Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. Food Funct. 14, 6896–6913 (2023).
-
Fan, X. et al. Intravital imaging of translocated bacteria via fluorogenic labeling of gut microbiota in situ. Proc. Natl. Acad. Sci. USA 122, e2415845122 (2025).
-
Xiao, H. et al. Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function. Int. J. Biol. Macromol. 180, 633–642 (2021).
-
Wang, Y. et al. Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance. Acta Pharm. Sin. B 14, 3901–3915 (2024).
-
Manning, J. C. et al. Lectins: a primer for histochemists and cell biologists. Histochem. Cell Biol. 147, 199–222 (2017).
-
Wu, A. M., Dudek, A. & Chen, Y. L. Recognition factors of Dolichos biflorus agglutinin (DBA) and their accommodation sites. Glycoconj. J. 40, 383–399 (2023).
-
Lastovickova, M., Strouhalova, D. & Bobalova, J. Use of lectin-based affinity techniques in breast cancer glycoproteomics: a review. J. Proteome Res. 19, 1885–1899 (2020).
-
Engevik, M. A. et al. Human Clostridium difficile infection: altered mucus production and composition. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G510–G524 (2014).
-
Wen, X. et al. Pectin supplementation ameliorates intestinal epithelial barrier function damage by modulating intestinal microbiota in lipopolysaccharide-challenged piglets. J. Nutr. Biochem. 109, 109107 (2022).
-
Bergstrom, K. et al. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol. 10, 91–103 (2017).
-
Nyström, E. E. L. et al. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function. Science 372, eabb1590 (2021).
-
Singh, V. et al. Chronic inflammation in ulcerative colitis causes long-term changes in goblet cell function. Cell. Mol. Gastroenterol. Hepatol. 13, 219–232 (2022).
-
Ma, J. et al. Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells. Phytomedicine 111, 154660 (2023).
-
Nomura, E. et al. Characteristics of the mucosal surface on scanning electron microscopy in patients with remitting ulcerative colitis. Dig. Dis. Sci. 66, 3141–3148 (2021).
-
Taniguchi, M. et al. Sialylation shapes mucus architecture inhibiting bacterial invasion in the colon. Mucosal Immunol. 16, 624–641 (2023).
-
Meziu, E. et al. Visualization of the structure of native human pulmonary mucus. Int. J. Pharm. 597, 120238 (2021).
-
Almeqdadi, M., Mana, M. D., Roper, J. & Yilmaz, ÖH. Gut organoids: mini-tissues in culture to study intestinal physiology and disease. Am. J. Physiol. Cell Physiol. 317, C405–C419 (2019).
-
Mithal, A. et al. Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells. Nat. Commun. 11, 215 (2020).
-
Villegas-Novoa, C., Wang, Y., Sims, C. E. & Allbritton, N. L. Creation of a spatially complex mucus bilayer on an in vitro colon model. Sci. Rep. 14, 16849 (2024).
-
Zhang, D., Zhou, X., Zhou, W., Cui, S. W. & Nie, S. Intestinal organoids: a thriving and powerful tool for investigating dietary nutrients-intestinal homeostasis axis. Food Res. Int. 172, 113109 (2023).
-
Bozzetti, V. & Senger, S. Organoid technologies for the study of intestinal microbiota–host interactions. Trends Mol. Med. 28, 290–303 (2022).
-
Liu, Y. et al. Ginseng-derived nanocellulose alleviates murine colitis through modulation of inflammation, epithelial barrier and gut microbiome. Chem. Eng. J. 506, 160254 (2025).
-
Poletti, M., Arnauts, K., Ferrante, M. & Korcsmaros, T. Organoid-based models to study the role of host-microbiota interactions in IBD. J. Crohn’s. Colitis 15, 1222–1235 (2021).
-
Son, Y. S. et al. Maturation of human intestinal organoids in vitro facilitates colonization by commensal lactobacilli by reinforcing the mucus layer. FASEB J. 34, 9899–9910 (2020).
-
Yang, N. et al. A mucus layer derived from porcine intestinal organoid air–liquid interface monolayer attenuates swine enteric coronavirus infection by antiviral activity of Muc2. BMC Biol. 22, 297 (2024).
-
Farhang Doost, N. & Srivastava, S. K. A comprehensive review of organ-on-a-chip technology and its applications. Biosensors 14, 225 (2024).
-
Ashammakhi, N. et al. Gut-on-a-chip: current progress and future opportunities. Biomaterials 255, 120196 (2020).
-
Nelson, M. T. et al. Evaluation of human performance aiding live synthetically engineered bacteria in a gut-on-a-chip. ACS Biomater. Sci. Eng. 9, 5136–5150 (2023).
-
Thomas, D. P., Zhang, J., Nguyen, N.-T. & Ta, H. T. Microfluidic gut-on-a-chip: fundamentals and challenges. Biosensors 13, 136 (2023).
-
Wang, H., Cong, X., Mingqian, T. & Su, W. Advanced gut-on-chips for assessing carotenoid absorption, metabolism, and transport. Crit. Rev. Food Sci. Nutr. 65, 1344–1362 (2025).
-
Garcia-Gutierrez, E. & Cotter, P. D. Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions. Crit. Rev. Microbiol. 48, 463–488 (2022).
-
Shin, Y. C., Than, N., Min, S., Shin, W. & Kim, H. J. Modelling host–microbiome interactions in organ-on-a-chip platforms. Nat. Rev. Bioeng. 2, 175–191 (2024).
-
Jing, B. et al. Chitosan oligosaccharides regulate the occurrence and development of enteritis in a human gut-on-a-chip. Front. Cell Dev. Biol. 10, 877892 (2022).
-
McCoy, R. et al. Mucus-on-a-chip: investigating the barrier properties of mucus with organic bioelectronics. J. Mater. Chem. B 13, 577–587 (2025).
-
Sharpen, J. D. A. et al. Transglutaminase 3 crosslinks the secreted gel-forming mucus component Mucin-2 and stabilizes the colonic mucus layer. Nat. Commun. 13, 45 (2022).
-
Sotres, J., Jankovskaja, S., Wannerberger, K. & Arnebrant, T. Ex-vivo force spectroscopy of intestinal mucosa reveals the mechanical properties of mucus blankets. Sci. Rep. 7, 7270 (2017).
-
Abrami, M. et al. Mucus structure, viscoelastic properties, and composition in chronic respiratory diseases. Int. J. Mol. Sci. 25, 1933 (2024).
-
Liu, C., Jiang, X., Gan, Y. & Yu, M. Engineering nanoparticles to overcome the mucus barrier for drug delivery: design, evaluation and state-of-the-art. Med. Drug Discov. 12, 100110 (2021).
-
Mura, P., Maestrelli, F., Cirri, M. & Mennini, N. Multiple roles of chitosan in mucosal drug delivery: an updated review. Mar. Drugs 20, 335 (2022).
-
Collado-González, M., González Espinosa, Y. & Goycoolea, F. M. Interaction between chitosan and mucin: fundamentals and applications. Biomimetics 4, 32 (2019).
-
Qi, Y. et al. Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs. J. Control. Release 360, 831–841 (2023).
-
Sun, L. et al. Mucus-penetrating alginate-chitosan nanoparticles loaded with berberine hydrochloride for oral delivery to the inflammation site of ulcerative colitis. AAPS PharmSciTech 23, 179 (2022).
-
Menchicchi, B. et al. Biophysical analysis of the molecular interactions between polysaccharides and mucin. Biomacromolecules 16, 924–935 (2015).
-
Fernández-Lainez, C., aan de Stegge, M., Silva-Lagos, L. A., López-Velázquez, G. & de Vos, P. β(2 → 1)-β(2 → 6) branched graminan-type fructans and β(2 → 1) linear fructans impact mucus-related and endoplasmic reticulum stress-related genes in goblet cells and attenuate inflammatory responses in a fructan dependent fashion. Food Funct. 14, 1338–1348 (2023).
-
Song, W. et al. Modulating the gut microbiota is involved in the effect of low-molecular-weight Glycyrrhiza polysaccharide on immune function. Gut Microbes 15, 2276814 (2023).
-
Zeng, X. et al. Analysis of metagenome and metabolome disclosed the mechanisms of Dendrobium officinale polysaccharide on DSS-induced ulcerative colitis-affected mice. Int. J. Biol. Macromol. 277, 134229 (2024).
-
Wang, X. et al. Bacteroides methylmalonyl-CoA mutase produces propionate that promotes intestinal goblet cell differentiation and homeostasis. Cell Host Microbe 32, 63–78.e7 (2024).
-
Yang, J., Qin, K., Sun, Y. & Yang, X. Microbiota-accessible fiber activates short-chain fatty acid and bile acid metabolism to improve intestinal mucus barrier in broiler chickens. Microbiol. Spectr. 12, e02065-23 (2023).
-
Zhao, T. et al. Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota. npj Biofilms Microbiomes 9, 97 (2023).
-
Shuoker, B. et al. Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria. Nat. Commun. 14, 1833 (2023).
-
Hyun, G. H. et al. Mechanisms of interactions in pattern-recognition of common glycostructures across pectin-derived heteropolysaccharides by Toll-like receptor 4. Carbohydr. Polym. 314, 120921 (2023).
-
Zhang, X., Qi, C., Guo, Y., Zhou, W. & Zhang, Y. Toll-like receptor 4-related immunostimulatory polysaccharides: primary structure, activity relationships, and possible interaction models. Carbohydr. Polym. 149, 186–206 (2016).
-
Li, G. et al. Dietary polysaccharides from dragon fruit pomace, a co-product of the fruit processing industry, exhibit therapeutic potential in high-fat diet-induced metabolic disorders. Food Res. Int. 203, 115818 (2025).
-
Zhao, Z.-L. et al. Protective effect of mussel polysaccharide on cyclophosphamide-induced intestinal oxidative stress injury via Nrf2-Keap1 signaling pathway. Food Sci. Nutr. 11, 4233–4245 (2023).
-
Kurl, S. et al. Challenges, opportunities, and future prospects of polysaccharide-based nanoparticles for colon targeting: a comprehensive review. Carbohydr. Polym. Technolo. Appl. 6, 100361 (2023).
-
dos Santos, A. M. et al. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: challenges, advances and future perspectives. J. Control. Release 334, 353–366 (2021).
-
Cui, M., Zhang, M. & Liu, K. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: a review. Carbohydr. Polym. 272, 118530 (2021).
